UNION-BANCAIRE-PRIVÉE
Growth in developed economies continues to firm up. The United States briefly lost some momentum as a result of tough winter weather but the general trend remains good and the latest data shows that the economy has recovered from this soft patch. The euro area is still showing signs of improvement driven by the strong economic recovery in peripheral countries. Meanwhile central banks remain extremely cautious: the ECB and the BoJ have both intimated that they are prepared to implement extra and extraordinary stimulus measures. The Fed is to carry on gradually trimming its asset-buying program (so-called “tapering”) and any rise in rates is still a long way off.
This is a positive environment for risky assets and high-yield spreads in particular, which continue to offer attractive valuations via high-yield CDS indices. They remain undervalued, as highlighted by the 6.4% implied default rate while expectations for default rates this year and next stand at only 2.0%, well below the historical average of 4.0%. Considering that high-yield CDS indices bear no interest risk and offer high liquidity in all market conditions, the value proposition for CDS spreads is compelling.
Furthermore, high-yield CDS indices are now modelled on the clearing practices in the interest-rate futures markets, enabling strategies that use CDS indices – such as Union Bancaire Privée’s Global High Yield strategy – to benefit from a zero counterparty risk. Also, by aligning itself with the US regulators’ schedule, which is ahead of Europe’s, Union Bancaire Privée’s fixed-income team offers its European investors a significant advantage, as they can now benefit from daily liquidity with no counterparty risk when using CDSs.
In three years, Union Bancaire Privée’s Global High Yield strategy has amassed USD 1.48 billion in assets and has outperformed all of its peers, thanks to a unique management approach that uses, amongst other things, CDSs and an exclusive top-down investment policy focusing on analysing macroeconomic conditions and identifying the themes driving the financial markets – unlike most high-yield bond fund managers, who adopt an exclusively bottom-up approach which favours bond selection.
With this approach they are able to adjust the strategy’s exposure according to their expectations, across three dimensions: the exposure to the high-yield market; the geographical exposure to US and European high-yield markets; and the interest-rate exposure, which has been very limited since launch and is practically zero today. Furthermore, the use of CDSs enables the team to adopt a unique positioning, as the strategy is one of the only ones to use these instruments, and to enjoy almost perfect liquidity, given that traditional high-yield bond funds’ liquidity is usually hampered by transaction costs in excess of 1.5%. As well as this, CDSs offer an additional advantage over traditional bond investments in terms of returns. This can be put down to two factors: firstly, whereas the bond universe is finite (increased demand causes prices to rise and returns to fall), the CDS market is not subject to capacity constraints; secondly, CDSs – in contrast to bonds – bear no early repayment call, which preserves their return potential.
The strategy has outperformed its peers in spite of the fact that one of its key characteristics – namely an almost zero exposure to interest rates – actually worked against it between 2011 and 2012 because of the bearish rate environment. The strategy should therefore continue to perform strongly in the current positive environment.
The information and opinions contained herein were prepared by Union
Bancaire Privée, UBP SA (hereinafter, “UBP”).
The information
herein was obtained from various sources and is believed by UBP to be
reliable but UBP makes no representation as to the accuracy or
completeness of such information. Opinions, estimates and projections in
this document constitute the current judgment of the author as of the
date of this document and are subject to change without notice. UBP has
no obligation to update, modify or amend this document.
This
document is provided for information purposes only. It is not to be
construed as an offer to buy or sell or solicitation of an offer to buy
or sell any financial instruments or to participate in any particular
trading strategy in any jurisdiction. The financial instruments
discussed in this document may not be suitable for all investors and
these materials should not be regarded by recipients as a substitute for
the exercise of their own judgment. Investors must make their own
investment decisions using their own independent advisors as they
believe necessary and based upon their specific financial situation and
their investment objectives. Investors should be aware that foreign
exchange rates may have a negative effect on the price or value of, or
the income derived from, an investment denominated in a foreign
currency. Furthermore, past performance is not necessarily indicative of
future results.
UBP may make a market in, or may, as principal or
agent, buy or sell securities of the companies mentioned in this
document or derivatives thereon. UBP may have a financial interest in
the companies mentioned in this document, including a long or short
position in their securities, and or options, futures or other
derivative instruments based thereon.
About Union Bancaire Privée (UBP)
UBP is one of
Switzerland’s leading private banks, and is among the best-capitalised,
with a Tier I ratio of 29%. The Bank is specialised in the field of
wealth management for both private and institutional clients. It is
based in Geneva and employs about 1,350 people in some twenty locations
worldwide; it held CHF 87.7 billion (USD 98.6 billion) in assets under
management as at 31 December 2013.
www.ubp.com
Contact:
Union Bancaire Privée
Jerome Koechlin, Tel: +41 58 819 26 40
Head
of Corporate Communications
e-mail: jko@ubp.ch
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Rimini Street Announces Upcoming 2025 Investor Conference Schedule15.5.2025 22:51:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that Michael L. Perica, chief financial officer, and Dean Pohl, vice president, treasurer and investor relations, will be presenting and meeting with investors one-on-one and in small group meetings at the following conferences: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515374696/en/ Rimini Street Announces Upcoming 2025 Investor Conference Schedule May 28, 2025: Craig-Hallum 22nd Annual Institutional Investor Conference, Minneapolis May 29, 2025: TD Cowen 53rd Annual TMT Conference, New York City Fireside Chat: 1:15 pm Eastern, webcast link June 24-26, 2025: Roth 15th Annual London Conference, London To schedule a meeting please contact your salesperson or Rimini Street Investor Relations at IR@rimin
Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States15.5.2025 20:30:00 CEST | Press release
Zynyz® (retifanlimab-dlwr), a PD-1 inhibitor, is now approved for the treatment of advanced squamous cell carcinoma of the anal canal (SCAC) in combination with chemotherapy and as a monotherapyPatients with SCAC treated with Zynyz achieved a statistically significant improvement in progression-free survival and improvement in overall survival Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz® (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC). In addition, the FDA granted approval for Zynyz as a single agent for the treatment of adult patients with locally recurrent or with metastatic SCAC with disease progression on or intolerance to platinum-based chemotherapy. Thi
DDC Announces Record 2024 Growth and Strategic Bitcoin Reserve Initiative in Shareholder Letter by Founder & CEO Norma Chu15.5.2025 20:23:00 CEST | Press release
DDC Enterprise Ltd. (NYSEAM: DDC), today released its 2024 full year results alongside a Shareholder Letter from Founder, Chairwoman, and CEO Norma Chu, underscoring the company’s positive financial performance and unveiling a pioneering Bitcoin accumulation strategy poised to redefine long-term value creation. To Our Valued Shareholders, 2024 was a year of transformative growth and strategic milestones for DDC. I am thrilled to share that we not only met our financial forecasts but exceeded expectations, delivering strong performance across key metrics while laying the groundwork for an even more exciting future. As we enter 2025, our momentum is accelerating, driven by disciplined execution and a bold new chapter in our corporate strategy. 2024 Financial & Operational HighlightsRevenue Growth: USD 37.4 million, a 33% year-over-year increase, propelled by the strategic acquisition of U.S. brands and sustained resilience in our core China operations. Margin Expansion: Gross profit marg
Ras Al Khaimah’s Strong Economic and Investment Environment Validated by Fitch Affirmation of ‘A+’ Credit Rating, With Stable Outlook15.5.2025 20:18:00 CEST | Press release
The positive rating reflects the Emirate’s strong long-term growth prospects and ongoing economic diversification Ras Al Khaimah’s strategic approach to sustainable, cross-sector growth and strong economic and investment environment has been validated by international credit rating agency Fitch, which reaffirmed the rating at ‘A+’ with a stable outlook. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515907689/en/ Ras Al Khaimah’s strong economic and investment environment validated by Fitch affirmation of ‘A+’ credit rating, with Stable Outlook (Photo: AETOSWire) Ras Al Khaimah Government welcomed the announcement as an endorsement of the Emirate’s resilient and expanding economy, sound fiscal management and the clear vision and unwavering commitment of its leadership to sustainable, long-term development and growth. The Emirate’s landmark tourism projects, including a major integrated resort, luxury hotels and world-clas
Cessna Citation CJ4 Gen3 Flight Test Program Advances Through Milestones as Second Test Article Takes Flight15.5.2025 20:00:00 CEST | Press release
Textron Aviation today announced a major program milestone for the Cessna Citation CJ4 Gen3 flight test program with the successful first flight of a second test article — P1. Testing on the P1 aircraft will focus on avionics, human factors and interiors. The Citation CJ4 Gen3 business jet is designed to keep pilots a step ahead in the cockpit by offering the next-generation Garmin G3000 PRIME avionics along with the most standard features in its class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515438856/en/ Cessna Citation CJ4 Gen3 flight test program advances through milestones as second test article takes flight. (Photo Credit: Textron Aviation) The Cessna Citation CJ4 Gen3 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. “This achievement continues the forward momentum of the CJ4 Gen3 program and reflects the dedication and expertise of our team in designing, certifying an
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum